π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
This prospective observational study aims to understand the effects of diff...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06587776
The main objective of the present study is to verify, in vivo, whether shea...
Status
Unknown
Location
Medical University of Warsaw
Start Date
2023-07-21
Trial ID
NCT06275399
Treatments Being Tested
Optical coherence tomography (OCT) offers a high-resolution intravascular i...
Status
Not Yet Recruiting
Location
Northern Hospital
Start Date
2024-04-01
Trial ID
NCT06339021
Treatments Being Tested
The purpose of this study is to assess the tolerability and efficacy of ran...
Status
Completed
Location
Texas Retina Associates
Start Date
2014-09-23
Trial ID
NCT02222610
Treatments Being Tested
Glaucoma is one of the leading causes for blindness in industrialized count...
Status
Completed
Location
Medical University of Vienna
Start Date
2015-09-11
Trial ID
NCT02548676
Treatments Being Tested
This study is to establish the primary hypothesis thatAI -QCA guided PCI is...
Status
Completed
Location
Sejong General Hospital
Start Date
2022-10-04
Trial ID
NCT05388357
Treatments Being Tested
The aim of the study is to identify morphological and functional biomarkers...
Status
Unknown
Location
Prof. Stanislao Rizzo
Start Date
2021-01-15
Trial ID
NCT05747144
In this study, we aim to evaluate the efficacy and safety of an individuali...
Status
Completed
Location
Singapore National Eye Centre
Start Date
2021-02-01
Trial ID
NCT03941587